Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
Introduction Relationships between glycemic-lowering effects of sodium glucose co-transporter 2 inhibitors and impact on kidney and cardiovascular outcomes are uncertain.Research design and methods We analyzed 4395 individuals with prebaseline and postbaseline hemoglobin A1c (HbA1c) randomized to ca...
主要な著者: | , , , , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
BMJ Publishing Group
2023-05-01
|
シリーズ: | BMJ Open Diabetes Research & Care |
オンライン・アクセス: | https://drc.bmj.com/content/11/3/e003270.full |